204 related articles for article (PubMed ID: 32991944)
1. Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?
Giralt T; Ribas N; Freixa X; Sabaté M; Caldentey G; Tizón-Marcos H; Carrillo X; García-Picart J; Lidón RM; Cárdenas M; Pérez-Fernández S; Mauri J; Vaquerizo B
Int J Cardiol; 2021 Feb; 325():9-15. PubMed ID: 32991944
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent effects of unfractionated heparin in patients with ST-elevation myocardial infarction transferred for primary angioplasty.
Giralt T; Carrillo X; Rodriguez-Leor O; Fernandez-Nofrerias E; Rueda F; Serra-Flores J; Viguer JM; Mauri J; Curos A; Bayes-Genis A
Int J Cardiol; 2015 Nov; 198():70-4. PubMed ID: 26159240
[TBL] [Abstract][Full Text] [Related]
3. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Janzon M; Mielecki W; Zmudka K; Dubiel JS; Dudek D
Kardiol Pol; 2012; 70(3):215-21. PubMed ID: 22430397
[TBL] [Abstract][Full Text] [Related]
4. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Ocek AH
Coron Artery Dis; 2014 Mar; 25(2):159-66. PubMed ID: 24326783
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
6. Platelet to Lymphocyte Ratio Can be a Predictor of Infarct-Related Artery Patency in Patients With ST-Segment Elevation Myocardial Infarction.
Yayla Ç; Akboğa MK; Canpolat U; Akyel A; Yayla KG; Doğan M; Yeter E; Aydoğdu S
Angiology; 2015 Oct; 66(9):831-6. PubMed ID: 25712290
[TBL] [Abstract][Full Text] [Related]
7. The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
d'Entremont MA; Laferrière C; Bérubé S; Couture ÉL; Lepage S; Huynh T; Verreault-Julien L; Karzon A; Desgagnés N; Nguyen M
Catheter Cardiovasc Interv; 2021 Mar; 97(4):591-599. PubMed ID: 32860646
[TBL] [Abstract][Full Text] [Related]
8. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Estévez-Loureiro R; Salgado-Fernández J; Marzoa-Rivas R; Barge-Caballero E; Pérez-Pérez A; Noriega-Concepción V; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A; Kaski JC
Thromb Res; 2009 Nov; 124(5):536-40. PubMed ID: 19467699
[TBL] [Abstract][Full Text] [Related]
9. Early unfractionated heparin treatment in patients with STEMI - trial design and rationale.
Fister M; Mikuz U; Ziberna K; Franco D; Radsel P; Bunc M; Noc M; Goslar T
PLoS One; 2024; 19(5):e0303376. PubMed ID: 38723003
[TBL] [Abstract][Full Text] [Related]
10. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
[TBL] [Abstract][Full Text] [Related]
11. Impact of early abciximab administration on myocardial reperfusion in patients with ST-segment elevation myocardial infarction pretreated with 600 mg of clopidogrel before percutaneous coronary intervention.
Dudek D; Rakowski T; Bartus S; Giszterowicz D; Dobrowolski W; Zmudka K; Zalewski J; Ochala A; Wieja P; Janus B; Dziewierz A; Legutko J; Bryniarski L; Dubiel JS
J Thromb Thrombolysis; 2010 Oct; 30(3):347-53. PubMed ID: 20373130
[TBL] [Abstract][Full Text] [Related]
12. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
13. Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
Li J; Zhou Y; Zhang Y; Zheng J
BMC Cardiovasc Disord; 2018 Jun; 18(1):125. PubMed ID: 29940881
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Infarct-Related Artery Patency Before Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (from the FAST-MI 2010 Registry).
Bailleul C; Puymirat E; Aissaoui N; Schiele F; Ducrocq G; Coste P; Blanchard D; Brasselet C; Elbaz M; Steg PG; Le Breton H; Bonnefoy-Cudraz E; Montalescot G; Cottin Y; Goldstein P; Ferrières J; Simon T; Danchin N;
Am J Cardiol; 2016 Jan; 117(1):17-21. PubMed ID: 26541905
[TBL] [Abstract][Full Text] [Related]
16. Chronic statin treatment is a predictor of pre-interventional infarct-related artery patency in patients with ST elevation myocardial infarction treated with percutaneous coronary intervention.
Özbiçer S; Gür M; Kalkan G; Özaltun B; Çaylı M
Kardiol Pol; 2018; 76(3):542-547. PubMed ID: 29350388
[TBL] [Abstract][Full Text] [Related]
17. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C
Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542
[TBL] [Abstract][Full Text] [Related]
18. Investigating the Correlation between Serum Amyloid A and Infarct-Related Artery Patency Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients.
Ji H; Chen S; Hu Q; He Y; Zhou L; Xie J; Pan H; Tong X; Wu C
Angiology; 2024 Jul; 75(6):585-594. PubMed ID: 37402552
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
